Quale sarebbe il prezzo per Renascience Inc. (4889)

Il prezzo per Renascience Inc. (4889) è $8.49

Qual è la capitalizzazione di mercato per Renascience Inc. (4889)

La capitalizzazione di mercato per Renascience Inc. (4889) è $117.03M

Renascience Inc. (4889) Prezzo e Capitalizzazione di Mercato

Renascience Inc., established in 2000 and based in Tokyo, Japan, is actively engaged in pioneering and bringing to market pharmaceuticals and medical devices throughout Japan. The company's pipeline includes RS5614, a PAI-1 inhibitor that has reached Phase 3 clinical trials for a wide range of indications such as chronic myeloid leukemia, malignant melanoma, non-small cell lung cancer, novel coronavirus infections, and FGF23-related hypophosphatemic rickets. Another PAI-1 inhibitor, RS5441, is currently in Phase 1 trials for various dermatological conditions. Additionally, RS8001, a water-soluble vitamin, is undergoing Phase 2 clinical development for the treatment of premenstrual syndrome/premenstrual dysphoric mood disorder, autism spectrum disorder, and menopausal disorder. Beyond its pharmaceutical ventures, Renascience is also advancing the RS9001 disposable ultrafine endoscope, alongside developing artificial intelligence-driven medical solutions and comprehensive diagnostic tools.

Il prezzo per 4889	Attivo B	Capitalizzazione del mercato a B	Risultati
$378,270 $117.03M	NVDA	$5.211T	+4,452,901.53%
$330,028 $117.03M	AAPL	$4.547T	+3,884,995.69%
$302,136 $117.03M	GOOG	$4.162T	+3,556,645.30%
$260,785 $117.03M	MSFT	$3.593T	+3,069,861.64%
$202,721 $117.03M	AMZN	$2.793T	+2,386,333.36%

Il prezzo per 4889

Attivo B

Capitalizzazione del mercato a B

Risultati

$378,270 $117.03M